Intrachromosomal amplification of chromosome 21 in Korean pediatric patients with B-cell precursor acute lymphoblastic leukemia in a single institution
BACKGROUND: Intrachromosomal amplification of chromosome 21 (iAMP21), defined as the presence of three or more RUNX1 signals on one marker chromosome, is a distinct cytogenetic subgroup of childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL) that is known to have a poor prognosis when t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503886/ https://www.ncbi.nlm.nih.gov/pubmed/28698845 http://dx.doi.org/10.5045/br.2017.52.2.100 |
_version_ | 1783249172387856384 |
---|---|
author | Yang, Mina Yi, Eun Sang Kim, Hee Jin Yoo, Keon Hee Koo, Hong Hoe Kim, Sun-Hee |
author_facet | Yang, Mina Yi, Eun Sang Kim, Hee Jin Yoo, Keon Hee Koo, Hong Hoe Kim, Sun-Hee |
author_sort | Yang, Mina |
collection | PubMed |
description | BACKGROUND: Intrachromosomal amplification of chromosome 21 (iAMP21), defined as the presence of three or more RUNX1 signals on one marker chromosome, is a distinct cytogenetic subgroup of childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL) that is known to have a poor prognosis when treated with standard therapy. The aim of this study was to evaluate the clinical characteristics of Korean children with iAMP21. METHODS: The cytogenetic data from BCP-ALL children were reviewed. The ETV6/RUNX1 ES Dual Color Probe was used for fluorescence in situ hybridization (FISH). RESULTS: In total, 295 children were included. Of these, 10 patients (3.4%) had iAMP21. The median age of iAMP21 patients was 9 years, and the median value of white blood cell count was 5.09×10(9)/L. Slow early treatment response was observed more in iAMP21 patients. Patients with iAMP21 had a higher incidence of relapse and worse survival rates. In patients with iAMP21, the estimated 10-year cumulative incidence of relapse was 53.3%. The estimated 10-year event-free survival and overall survival rate were 46.7% and 64.8%, respectively. Most cases of leukemic relapse developed in the late period (median, 43 mo). In multivariate analysis, high risk group was the only factor that had a significant impact on death. CONCLUSION: The existence of iAMP21 was related to delayed treatment response and was likely to affect increased relapse and death in the late period. Further studies are needed to reveal its effect on BCP-ALL treatment outcomes and its role as an independent prognostic factor. |
format | Online Article Text |
id | pubmed-5503886 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
record_format | MEDLINE/PubMed |
spelling | pubmed-55038862017-07-11 Intrachromosomal amplification of chromosome 21 in Korean pediatric patients with B-cell precursor acute lymphoblastic leukemia in a single institution Yang, Mina Yi, Eun Sang Kim, Hee Jin Yoo, Keon Hee Koo, Hong Hoe Kim, Sun-Hee Blood Res Original Article BACKGROUND: Intrachromosomal amplification of chromosome 21 (iAMP21), defined as the presence of three or more RUNX1 signals on one marker chromosome, is a distinct cytogenetic subgroup of childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL) that is known to have a poor prognosis when treated with standard therapy. The aim of this study was to evaluate the clinical characteristics of Korean children with iAMP21. METHODS: The cytogenetic data from BCP-ALL children were reviewed. The ETV6/RUNX1 ES Dual Color Probe was used for fluorescence in situ hybridization (FISH). RESULTS: In total, 295 children were included. Of these, 10 patients (3.4%) had iAMP21. The median age of iAMP21 patients was 9 years, and the median value of white blood cell count was 5.09×10(9)/L. Slow early treatment response was observed more in iAMP21 patients. Patients with iAMP21 had a higher incidence of relapse and worse survival rates. In patients with iAMP21, the estimated 10-year cumulative incidence of relapse was 53.3%. The estimated 10-year event-free survival and overall survival rate were 46.7% and 64.8%, respectively. Most cases of leukemic relapse developed in the late period (median, 43 mo). In multivariate analysis, high risk group was the only factor that had a significant impact on death. CONCLUSION: The existence of iAMP21 was related to delayed treatment response and was likely to affect increased relapse and death in the late period. Further studies are needed to reveal its effect on BCP-ALL treatment outcomes and its role as an independent prognostic factor. Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2017-06 2017-06-22 /pmc/articles/PMC5503886/ /pubmed/28698845 http://dx.doi.org/10.5045/br.2017.52.2.100 Text en © 2017 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Yang, Mina Yi, Eun Sang Kim, Hee Jin Yoo, Keon Hee Koo, Hong Hoe Kim, Sun-Hee Intrachromosomal amplification of chromosome 21 in Korean pediatric patients with B-cell precursor acute lymphoblastic leukemia in a single institution |
title | Intrachromosomal amplification of chromosome 21 in Korean pediatric patients with B-cell precursor acute lymphoblastic leukemia in a single institution |
title_full | Intrachromosomal amplification of chromosome 21 in Korean pediatric patients with B-cell precursor acute lymphoblastic leukemia in a single institution |
title_fullStr | Intrachromosomal amplification of chromosome 21 in Korean pediatric patients with B-cell precursor acute lymphoblastic leukemia in a single institution |
title_full_unstemmed | Intrachromosomal amplification of chromosome 21 in Korean pediatric patients with B-cell precursor acute lymphoblastic leukemia in a single institution |
title_short | Intrachromosomal amplification of chromosome 21 in Korean pediatric patients with B-cell precursor acute lymphoblastic leukemia in a single institution |
title_sort | intrachromosomal amplification of chromosome 21 in korean pediatric patients with b-cell precursor acute lymphoblastic leukemia in a single institution |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503886/ https://www.ncbi.nlm.nih.gov/pubmed/28698845 http://dx.doi.org/10.5045/br.2017.52.2.100 |
work_keys_str_mv | AT yangmina intrachromosomalamplificationofchromosome21inkoreanpediatricpatientswithbcellprecursoracutelymphoblasticleukemiainasingleinstitution AT yieunsang intrachromosomalamplificationofchromosome21inkoreanpediatricpatientswithbcellprecursoracutelymphoblasticleukemiainasingleinstitution AT kimheejin intrachromosomalamplificationofchromosome21inkoreanpediatricpatientswithbcellprecursoracutelymphoblasticleukemiainasingleinstitution AT yookeonhee intrachromosomalamplificationofchromosome21inkoreanpediatricpatientswithbcellprecursoracutelymphoblasticleukemiainasingleinstitution AT koohonghoe intrachromosomalamplificationofchromosome21inkoreanpediatricpatientswithbcellprecursoracutelymphoblasticleukemiainasingleinstitution AT kimsunhee intrachromosomalamplificationofchromosome21inkoreanpediatricpatientswithbcellprecursoracutelymphoblasticleukemiainasingleinstitution |